Anemia is a common complication in chronic kidney disease (CKD), affecting a significant portion of patients with advanced stages. It primarily results from decreased erythropoietin production by the kidneys, which is essential for red blood cell production.1 Additionally, CKD often leads to iron deficiency, inflammation, and shortened red blood cell lifespan, all contributing to anemia. Symptoms include fatigue, weakness, and pallor. Management includes erythropoiesis-stimulating agents (ESAs) to stimulate red blood cell production, alongside iron supplementation to address iron deficiency.2 In some cases, blood transfusions may be necessary. Early detection and treatment are crucial to improving quality of life and preventing complications like cardiovascular disease. Regular monitoring of hemoglobin levels is important for optimal management in CKD patients. "1. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.642296/full 2. https://pmc.ncbi.nlm.nih.gov/articles/PMC9924302/"